Leerink Partners resumed coverage on PureTech Health plc with a new price target

9/9/24 7:42:36 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Leerink Partners resumed coverage of PureTech Health plc with a rating of Outperform and set a new price target of $45.00 from $58.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PRTC

Date	Price Target	Rating	Analyst
9/9/2024	$58.00 → $45.00	Outperform	Leerink Partners
1/7/2022	$76.00 → $70.00	Outperform	SVB Leerink
8/25/2021	$74.00 → $76.00	Outperform	SVB Leerink